162 related articles for article (PubMed ID: 20363623)
1. Squalenoyl nucleoside monophosphate nanoassemblies: new prodrug strategy for the delivery of nucleotide analogues.
Caron J; Reddy LH; Lepêtre-Mouelhi S; Wack S; Clayette P; Rogez-Kreuz C; Yousfi R; Couvreur P; Desmaële D
Bioorg Med Chem Lett; 2010 May; 20(9):2761-4. PubMed ID: 20363623
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies.
Hillaireau H; Dereuddre-Bosquet N; Skanji R; Bekkara-Aounallah F; Caron J; Lepêtre S; Argote S; Bauduin L; Yousfi R; Rogez-Kreuz C; Desmaële D; Rousseau B; Gref R; Andrieux K; Clayette P; Couvreur P
Biomaterials; 2013 Jul; 34(20):4831-8. PubMed ID: 23562054
[TBL] [Abstract][Full Text] [Related]
4. Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation.
Dosio F; Reddy LH; Ferrero A; Stella B; Cattel L; Couvreur P
Bioconjug Chem; 2010 Jul; 21(7):1349-61. PubMed ID: 20597546
[TBL] [Abstract][Full Text] [Related]
5. Squalenoyl nanomedicines as potential therapeutics.
Couvreur P; Stella B; Reddy LH; Hillaireau H; Dubernet C; Desmaële D; Lepêtre-Mouelhi S; Rocco F; Dereuddre-Bosquet N; Clayette P; Rosilio V; Marsaud V; Renoir JM; Cattel L
Nano Lett; 2006 Nov; 6(11):2544-8. PubMed ID: 17090088
[TBL] [Abstract][Full Text] [Related]
6. Freeze-drying of squalenoylated nucleoside analogue nanoparticles.
Bildstein L; Hillaireau H; Desmaële D; Lepêtre-Mouelhi S; Dubernet C; Couvreur P
Int J Pharm; 2009 Nov; 381(2):140-5. PubMed ID: 19782881
[TBL] [Abstract][Full Text] [Related]
7. Bis(benzoyloxybenzyl)-DiPPro nucleoside diphosphates of anti-HIV active nucleoside analogues.
Weinschenk L; Gollnest T; Schols D; Balzarini J; Meier C
ChemMedChem; 2015 May; 10(5):891-900. PubMed ID: 25847660
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.
McGuigan C; Bourdin C; Derudas M; Hamon N; Hinsinger K; Kandil S; Madela K; Meneghesso S; Pertusati F; Serpi M; Slusarczyk M; Chamberlain S; Kolykhalov A; Vernachio J; Vanpouille C; Introini A; Margolis L; Balzarini J
Eur J Med Chem; 2013; 70():326-40. PubMed ID: 24177359
[TBL] [Abstract][Full Text] [Related]
9. Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes.
Bildstein L; Pili B; Marsaud V; Wack S; Meneau F; Lepêtre-Mouelhi S; Desmaële D; Bourgaux C; Couvreur P; Dubernet C
Eur J Pharm Biopharm; 2011 Nov; 79(3):612-20. PubMed ID: 21784150
[TBL] [Abstract][Full Text] [Related]
10. Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies.
Bekkara-Aounallah F; Ambike A; Gref R; Couvreur P; Rosilio V
Int J Pharm; 2014 Aug; 471(1-2):75-82. PubMed ID: 24811925
[TBL] [Abstract][Full Text] [Related]
11. A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.
Rodríguez-Nogales C; Sebastián V; Irusta S; Desmaële D; Couvreur P; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2019 Nov; 144():165-173. PubMed ID: 31546021
[TBL] [Abstract][Full Text] [Related]
12. Improving the antitumor activity of squalenoyl-paclitaxel conjugate nanoassemblies by manipulating the linker between paclitaxel and squalene.
Caron J; Maksimenko A; Wack S; Lepeltier E; Bourgaux C; Morvan E; Leblanc K; Couvreur P; Desmaële D
Adv Healthc Mater; 2013 Jan; 2(1):172-85. PubMed ID: 23213041
[TBL] [Abstract][Full Text] [Related]
13. Prodrugs of Nucleoside Triphosphates as a Sound and Challenging Approach: A Pioneering Work That Opens a New Era in the Direct Intracellular Delivery of Nucleoside Triphosphates.
Camarasa MJ
ChemMedChem; 2018 Sep; 13(18):1885-1889. PubMed ID: 30152096
[TBL] [Abstract][Full Text] [Related]
14. γ-Non-Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV.
Zhao C; Jia X; Schols D; Balzarini J; Meier C
ChemMedChem; 2021 Feb; 16(3):499-512. PubMed ID: 33089929
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of modified thiopyrimidine nucleosides.
Attia AM; Sallam MA; Almehdi AA; Abbasi MM
Nucleosides Nucleotides; 1999 Oct; 18(10):2307-15. PubMed ID: 10616732
[TBL] [Abstract][Full Text] [Related]
16. Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues.
Gollnest T; Dinis de Oliveira T; Rath A; Hauber I; Schols D; Balzarini J; Meier C
Angew Chem Int Ed Engl; 2016 Apr; 55(17):5255-8. PubMed ID: 27008042
[TBL] [Abstract][Full Text] [Related]
17. Chemoenzymatic syntheses and anti-HIV-1 activity of glucose-nucleoside conjugates as prodrugs.
Rodríguez-Pérez T; Fernández S; Sanghvi YS; Detorio M; Schinazi RF; Gotor V; Ferrero M
Bioconjug Chem; 2010 Dec; 21(12):2239-49. PubMed ID: 21077659
[TBL] [Abstract][Full Text] [Related]
18. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
Jin Y; Yang F; Du L
Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
[TBL] [Abstract][Full Text] [Related]
19. Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting.
Arias JL; Reddy LH; Couvreur P
Langmuir; 2008 Jul; 24(14):7512-9. PubMed ID: 18540685
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.
Bildstein L; Dubernet C; Marsaud V; Chacun H; Nicolas V; Gueutin C; Sarasin A; Bénech H; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
J Control Release; 2010 Oct; 147(2):163-70. PubMed ID: 20691740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
